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A B S T R A C T
We present two cases of aortic valve replacement (AVR) in patients with protruding coronary artery
stents from the coronary ostia. In the ﬁrst case, an 87-year-old female was referred for AVR due to severe
aortic stenosis (AS). During the operation, we found stents protruding from the left and the right
coronary ostia into the aortic root. We performed AVR with a mechanical valve and coronary artery
bypass grafting with the saphenous vein to the left anterior descending artery. In the second case, a 77-
year-old female was referred for AVR due to severe AS with a history of healed infective endocarditis.
During surgery on the second patient, we found a stent protruding 7 mm from the left coronary ostium
into the aortic root. The edge of the stent was trimmed, and AVR with a mechanical valve was performed.
In both patients, we decided to use a mechanical prosthesis instead of a bioprosthesis because of the risk
of leaﬂet injury. Herein, we discuss some issues regarding patients with AS requiring AVR with prior
history of coronary stenting in the coronary ostia.
<Learning objective: To explore the problem of coronary stents protruding into the ostia in cases of
percutaneous coronary intervention of left main or right proximal lesions, which can compromise
subsequent aortic valve procedures including surgical aortic valve replacement or even transcatheter
aortic valve replacement thereafter.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Recent advances and reﬁnements in percutaneous coronary
intervention (PCI) enable successful stent placements even in
coronary ostial lesions in patients with left main and/or right
coronary artery diseases. Of those patients, some may develop
signiﬁcant aortic stenosis (AS), subsequently requiring surgical
aortic valve replacement (AVR). Herein, we describe two cases of
AVR with protruding coronary artery stents from the coronary
ostia, and discuss some issues related to intraoperative myocardial
protection and selection of valve prostheses.* Corresponding author at: 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507,
Japan. Tel.: +81 75 751 3780; fax: +81 75 751 3098.
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Patient 1
An 87-year-old female presented with chest pain at the
cardiology department in our hospital. Her past medical history
included coronary artery disease with PCI in the proximal right
coronary artery 5 years previously. Also, she had been diagnosed
with moderate AS 2 years previously. Cardiac catheterization
revealed signiﬁcant stenosis of the ostium of the left main trunk
(LMT) of her coronary artery. Thus, it was recommended that she
undergo coronary artery bypass grafting (CABG) and AVR, but she
refused. Therefore, she underwent PCI with a stent successfully
placed in the ostium of the LMT (Fig. 1). One month later, she
started to develop congestive heart failure symptoms such as
shortness of breath and pedal edema. Transthoracic echocardiog-
raphy (TTE) showed signiﬁcant progression of AS with a mean
pressure gradient across the aortic valve of 52 mmHg and an aortic reserved.
Fig. 1.
Left: coronary angiography showed a stent implanted in the left main trunk. Right: in the ﬁrst case, an intraoperative photograph shows the stents protruding
from the left and the coronary ostia.
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signiﬁcant stenosis in the proximal portion of the left anterior
descending artery (LAD). Based on these ﬁndings, she was referred
for AVR and CABG.
Through a median sternotomy, cardiopulmonary bypass was
established by ascending aortic and single right atrial cannulation.
After the ascending aorta was cross-clamped, the initial cardio-
plegia was delivered in antegrade fashion through the aortic root
cannula in addition to retrograde delivery through a coronary sinus
catheter. After a transverse aortotomy was performed, we
identiﬁed stents protruding from both the left and the right
coronary ostia into the aortic root (Fig. 1). We were not able to use a
selective coronary perfusion catheter because of the stents. Next,
we performed a distal anastomosis of a saphenous vein graft (SVG)
to the LAD. Additional myocardial protection was conducted with
direct perfusion through the SVG and retrograde perfusion. We
excised the calciﬁed aortic valve cusps and completely debrided
the annular calciﬁcation. The size of a 19-mm bioprosthesis was
tight because of the heavy calciﬁcation of the narrow aortic root.
Also, we thought that implanting a bioprosthesis in the supra-
annular position carried the risk of leaﬂet injury interfering with
both stents protruding from the coronary ostia. Therefore, we
chose a 17-mm St. Jude Medical Regent mechanical prosthesis
(St. Jude Medical, Minneapolis, MN, USA). The valve was sutured
using 1–0 braided polyester sutures. We conﬁrmed adequate
opening of the mechanical prosthetic valve leaﬂets with no
interference from the stents, and left both stents untouched. Her
postoperative course was somewhat complicated, requiringFig. 2.
Left: coronary angiography shows a stent placed in the left main trunk. Right:
the left coronary ostium.prolonged intensive care with tracheostomy for respiratory failure.
Her coronary CT angiography demonstrated a patent SVG to the
LAD and no signiﬁcant stenosis of both coronary stents. She was
subsequently discharged on day 62 postsurgery.
Patient 2
A 77-year-old female presented with fever at the internal
medicine department of our hospital. Her past medical history
included signiﬁcant coronary artery disease with prior multiple PCI
with stents to the LMT and all three coronary arteries 2 years
previously (Fig. 2). Her blood culture revealed Streptococccus mitis.
TTE revealed a 9-mm nonmobile mass on the noncoronary cusp of
the aortic valve. The aortic valve was heavily calciﬁed. The mean
gradient across the valve was measured at 39 mmHg and the aortic
valve area was 0.74 cm2. Transesophageal echocardiography
conﬁrmed vegetation on the noncoronary cusp, which was highly
luminescent and 9 mm  7 mm in size. She was diagnosed with
active infective endocarditis associated with signiﬁcant AS. After a
4-week course of antimicrobial therapy, she consulted with us for
AVR.
After standard cardiopulmonary bypass was established, the
ascending aorta was cross-clamped and antegrade cardioplegia
was delivered through the aortic root cannula. We found a stent
protruding approximately 7 mm from the left coronary ostium into
the aortic root (Fig. 2). We trimmed the edge of the stent in order to
proceed with AVR. This was carried out using heavy scissors, and
care was taken not to compromise the opening of the stent. During in the second case, an intraoperative photograph shows the stent protruding from
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because we were not able to place a selective antegrade coronary
cannula on the left coronary artery. Even after the excision of the
aortic cusps and meticulous debridement of the aortic annulus,
the size of a 19-mm bioprosthetic valve was tight because of the
heavily calciﬁed aortic root and narrow aortic annulus. Also,
we thought that the edge of the stent might injure the leaﬂet of the
bioprosthesis. Therefore, we chose a 17-mm mechanical valve, and
sutured it in the supra-annular position. Adequate opening of the
prosthetic valve was conﬁrmed with no interference from the
stent. Her postoperative course was uneventful. After an additional
4-week course of antimicrobial therapy, she was discharged on day
37 postsurgery.
Discussion
PCI has been the ﬁrst-line treatment in many patients with
coronary artery disease for many years. Recently, some interven-
tional cardiologists have become aggressive in treating those
patients who have LMT stenosis or ostial right coronary lesions.
During PCI, coronary ostia are often found to be covered by stents,
because it is recommended to fully extend the stents beyond the
edge of the lesion, resulting in stents protruding from coronary
ostia. In fact, Kang et al. [1] reported that stents protruded into the
aortic root in more than half of the cases of stenting of an ostial
lesion, and the length of the protrusion was 3.4  1.7 mm in the
LMT ostium and 2.4  1.4 mm in the right coronary ostium.
Therefore, we should keep in mind that stents protrude into the
aortic root in the majority of patients who undergo PCI with stents in
the coronary ostia. On the other hand, some of these patients may
develop severe AS thereafter, and subsequently require surgical AVR.
During the surgery, one may try to remove the protruding stents in
case they compromise the procedure. Although successful removal of
stents from the coronary ostia has been reported previously [2],
pulling the stent out of the coronary artery is likely to cause damage
to the intima, and result in signiﬁcant stenosis or even occlusion of
the coronary artery. Therefore, we should keep stents intact
whenever possible. However, in the second case reported here, the
stent protruded so far that it made it impossible to manipulate the
diseased aortic valve; thus, we needed to cut the protruding part. Care
needs to be taken not to bend the rest of the stent when trimming.
Myocardial protection is another issue of interest during
surgery. Unless there is signiﬁcant aortic insufﬁciency, antegrade
cardioplegia through an aortic root cannula is always the best
method to start with. However, after an aortotomy is performed, it
is impossible to give selective antegrade cardioplegia through the
stents protruding into the coronary ostia. Therefore, alternative
ways of delivering subsequent cardioplegia become necessary in
these patients. Retrograde cardioplegia through a coronary sinus
catheter is a valuable option; indeed, many surgeons routinely use
retrograde cardioplegia in aortic valve operations subsequently to
initial antegrade delivery through the aortic root cannula [3]. Also,
even in patients with signiﬁcant aortic insufﬁciency, one can still
give adequate antegrade cardioplegia through the aortic root
cannula to gain diastolic cardiac arrest by manipulating the left
ventricle to prevent over distension as needed.
According to the American College of Cardiology/American
Heart Association treatment guidelines for valvular patients,
bioprostheses are recommended for AVR patients aged 65 years
or older without a risk factor for thromboembolism [4]. In one case
report, a patient with a protruding stent underwent AVR with a
bioprosthesis [5]. If the protruding part of the stent is completelytrimmed without compromising the opening of the coronary
ostia, one can use a bioprosthetic valve in this circumstance.
However, we chose mechanical valves in both cases here because
of the possibility of injury to the bioprosthetic valve leaﬂets by
protruding stents. Even if a bioprosthesis is anatomically
implanted and there seems to be no interference between the
leaﬂets and the protruding stents in an arrested heart, a risk of
injury to the leaﬂets remains because the bioprosthetic valves
expand signiﬁcantly during systole under arterial pressure and
may hit the edge of the stents. Although there are several types of
bioprosthetic valves available, one must keep in mind the potential
risk of leaﬂet injury.
Transcatheter aortic valve replacement (TAVR) has emerged as
an important treatment of choice for patients with severe
symptomatic AS who are inoperable or at high operative risk
[6]. Evaluating preoperative comorbidities in these two cases,
TAVR may have been proposed as an alternative to surgical AVR
especially in case 1. However, TAVR may have been unsuccessful
because of the risks of damage to the protruding stents during
ballooning of the aortic valve or delivering the prosthesis, causing
myocardial ischemia, or incomplete expansion of the prosthesis
with leaﬂet injury causing malfunction of the prosthesis. The
present cases are useful for raising awareness of stents in the
coronary ostia when evaluating candidates for TAVR.
Conclusion
We present two cases of AVR in patients with stents protruding
from the coronary ostia into the aortic root. These two cases
highlight the importance of the correct choice of prostheses,
intraoperative myocardial protection, and suitability of TAVR in
such patients.
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